EORTC-related new drug discovery and development activities: role of the Pharmacology and Molecular Mechanisms Group

G.J. Peters, E. Chatelut, A.K. Larsen, N. Zaffaroni

Research output: Contribution to journal › Article › Academic › peer-review

3 Citations (Scopus)

Original language	English
Pages (from-to)	128-140
Journal	European Journal of Cancer. Supplement
Volume	10
Issue number	1
DOIs	https://doi.org/10.1016/S1359-6349(12)70022-8
Publication status	Published - 2012

Access to Document

@article{b62a1cb6c3b24937a830e6dd0b648f0c,

title = "EORTC-related new drug discovery and development activities: role of the Pharmacology and Molecular Mechanisms Group",

author = "G.J. Peters and E. Chatelut and A.K. Larsen and N. Zaffaroni",

year = "2012",

doi = "https://doi.org/10.1016/S1359-6349(12)70022-8",

language = "English",

volume = "10",

pages = "128--140",

journal = "European Journal of Cancer. Supplement",

issn = "1359-6349",

publisher = "Elsevier Limited",

number = "1",

}

TY - JOUR

T1 - EORTC-related new drug discovery and development activities: role of the Pharmacology and Molecular Mechanisms Group

AU - Peters, G.J.

AU - Chatelut, E.

AU - Larsen, A.K.

AU - Zaffaroni, N.

PY - 2012

Y1 - 2012

U2 - https://doi.org/10.1016/S1359-6349(12)70022-8

DO - https://doi.org/10.1016/S1359-6349(12)70022-8

M3 - Article

SN - 1359-6349

VL - 10

SP - 128

EP - 140

JO - European Journal of Cancer. Supplement

JF - European Journal of Cancer. Supplement

IS - 1

ER -